Literature DB >> 36267893

Family case studies: absence of Pseudomonas aeruginosa transmission in bronchiectasis.

Ruth Sobala1, Kristian Brooks1, John Davison1, Joanna Lumb1, Anthony De Soyza1,2.   

Abstract

Two case reports show lack of Pseudomonas aeruginosa transmission, despite household contact, in non-cystic fibrosis bronchiectasis (NCFB). This supports evidence that in NCFB, P. aeruginosa is poorly transmitted. This affects management strategies. https://bit.ly/3PeOcHy.
Copyright ©The authors 2022.

Entities:  

Year:  2022        PMID： 36267893      PMCID： PMC9574551          DOI： 10.1183/23120541.00280-2022

Source DB:  PubMed          Journal:  ERJ Open Res        ISSN： 2312-0541


  14 in total

1.  Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis.

Authors:  Anthony De Soyza; Audrey Perry; Amanda J Hall; Syba S Sunny; Kathy E Walton; Nazim Mustafa; Jane Turton; Dervla T Kenna; Craig Winstanley
Journal:  Eur Respir J       Date:  2013-10-31       Impact factor: 16.671

2.  Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology.

Authors:  Nina Cramer; Ludwig Sedlacek; Burkhard Tümmler; Tobias Welte
Journal:  Eur Respir J       Date:  2019-03-28       Impact factor: 16.671

Review 3.  A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.

Authors:  Simon Finch; Melissa J McDonnell; Hani Abo-Leyah; Stefano Aliberti; James D Chalmers
Journal:  Ann Am Thorac Soc       Date:  2015-11

4.  Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.

Authors:  P Robinson; R Carzino; D Armstrong; A Olinsky
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

Review 6.  Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.

Authors:  James D Chalmers; Felix C Ringshausen; Bridget Harris; J Stuart Elborn; Annette Posthumus; Charles S Haworth; Nicola Pilkington; Eva Polverino; Thomas Ruddy; Stefano Aliberti; Pieter C Goeminne; Craig Winstanley; Anthony De Soyza
Journal:  Eur Respir J       Date:  2018-01-11       Impact factor: 16.671

7.  Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

Authors:  Melissa J McDonnell; Stefano Aliberti; Pieter C Goeminne; Marcos I Restrepo; Simon Finch; Alberto Pesci; Lieven J Dupont; Thomas C Fardon; Robert Wilson; Michael R Loebinger; Dusan Skrbic; Dusanka Obradovic; Anthony De Soyza; Chris Ward; John G Laffey; Robert M Rutherford; James D Chalmers
Journal:  Lancet Respir Med       Date:  2016-11-16       Impact factor: 30.700

Review 8.  European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.

Authors:  Alan R Smyth; Scott C Bell; Snezana Bojcin; Mandy Bryon; Alistair Duff; Patrick Flume; Nataliya Kashirskaya; Anne Munck; Felix Ratjen; Sarah Jane Schwarzenberg; Isabelle Sermet-Gaudelus; Kevin W Southern; Giovanni Taccetti; Gerald Ullrich; Sue Wolfe
Journal:  J Cyst Fibros       Date:  2014-05       Impact factor: 5.482

9.  The bronchiectasis severity index. An international derivation and validation study.

Authors:  James D Chalmers; Pieter Goeminne; Stefano Aliberti; Melissa J McDonnell; Sara Lonni; John Davidson; Lucy Poppelwell; Waleed Salih; Alberto Pesci; Lieven J Dupont; Thomas C Fardon; Anthony De Soyza; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 30.528

Review 10.  Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics.

Authors:  Philip Mitchelmore; Catherine Wilson; David Hettle
Journal:  Curr Pulmonol Rep       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.